Section 15-850 - Prior authorizations for opioid antagonist(a) In this section, "opioid antagonist" means:(1) naloxone hydrochloride; or(2) any other similarly acting and equally safe drug approved by the federal Food and Drug Administration for the treatment of a drug overdose.(b)(1) This section applies to:(i) insurers and nonprofit health service plans that provide coverage for prescription drugs under individual, group, or blanket health insurance policies or contracts that are issued or delivered in the State; and(ii) health maintenance organizations that provide coverage for prescription drugs under individual or group contracts that are issued or delivered in the State.(2) An insurer, a nonprofit health service plan, or a health maintenance organization that provides coverage for prescription drugs through a pharmacy benefits manager is subject to the requirements of this section.(c) An entity subject to this section that includes on its formulary an opioid antagonist may apply a prior authorization requirement for an opioid antagonist only if the entity provides coverage for at least one formulation of the opioid antagonist without a prior authorization requirement.Added by 2017 Md. Laws, Ch. 572,Sec. 4, eff. 1/1/2018.Added by 2017 Md. Laws, Ch. 571,Sec. 4, eff. 1/1/2018.